Rar Bio-Tech Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2012.
2012 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Rar Bio-Tech Private Limited

Rar Bio-Tech Private Limited, a struck off private limited company, was established on 19 January 2012 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24233TG2012PTC078653. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Raghava Raju Datla (Director), Santosh Kumar Gupta (Director), Raghavenderrao Gajula (Director). It is based at 6-9-17, A-2, Co-Op Industrial Estate Balanagar, Hyderabad, Telangana, 500037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2012PTC078653

  • Registration Number

    078653

  • Incorporation Date

    19 January 2012

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 14 Year, 5 Months
Company report

Rar Bio-Tech Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Rar Bio-Tech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rar Bio-Tech Private Limited?
Current Directors
Name Designation Appointment Date Status
Raghava Raju Datla Director 19 Jan 2012 Current
Santosh Kumar Gupta Director 19 Jan 2012 Current
Raghavenderrao Gajula Director 19 Jan 2012 Current
Aditya Gupta Director 19 Jan 2012 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rar Bio-Tech.

Enhance accessibility to Rar Bio-Tech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rar Bio-Tech revenue growth over time
Rar Bio-Tech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rar Bio-Tech?

Unlock access to Rar Bio-Tech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rar Bio-Tech?

Unlock and access historical data on people associated with Rar Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rar Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rar Bio-Tech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rar Bio-Tech
Recent Activity within the Organization
  • Director Appointment

    Raghava Raju Datla was appointed as a Director was appointed as a Director on 19 Jan 2012 & has been associated with this company since 14 years 5 months . was recorded as a recent event.

  • Director Appointment

    Santosh Kumar Gupta was appointed as a Director was appointed as a Director on 19 Jan 2012 & has been associated with this company since 14 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Raghavenderrao Gajula was appointed as a Director was appointed as a Director on 19 Jan 2012 & has been associated with this company since 14 years 5 months . was completed.

  • Director Appointment

    The activity Aditya Gupta was appointed as a Director was appointed as a Director on 19 Jan 2012 & has been associated with this company since 14 years 5 months . was completed.

  • Company Incorporation

    Progress on Rar Bio-Tech Private Limited was registered on 19 Jan 2012 with Roc Hyderabad & aged 14 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rar Bio-Tech Private Limited?

The CIN of Rar Bio-Tech Private Limited is U24233TG2012PTC078653.

Where is Rar Bio-Tech Private Limited headquartered?

Rar Bio-Tech Private Limited is headquartered at 6-9-17, A-2, Co-Op Industrial Estate Balanagar, Hyderabad, Telangana, 500037.

When was Rar Bio-Tech Private Limited incorporated?

Rar Bio-Tech Private Limited was incorporated on 19 January 2012.

Who are the current directors of Rar Bio-Tech Private Limited?

The current directors of Rar Bio-Tech Private Limited are

What is the primary industry of Rar Bio-Tech Private Limited?

The primary industry of Rar Bio-Tech Private Limited is Pharma.

Is Rar Bio-Tech Private Limited a listed company?

Rar Bio-Tech Private Limited is unlisted.

What is the capital structure of Rar Bio-Tech Private Limited?

The authorized capital of Rar Bio-Tech Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available